Drug recall · January 30, 2019
HEPERAIN 50 mg/50 mL recall
Why: Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50 Units/50 mL (1 Unit/mL)
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
HEPERAIN 50 mg/50 mL (1mg/mL) Injectable Solution, Heparin Sodium 0.45% Sodium Chloride QS Heparin 50 Units 50 mL, Sterile single use syringe, Avella of Houston an FDA Registered 503B Outsourcing Facility 9265 Kirby Dr. Houston, TX 77054 (877) 794-0404 ---- NDC: 42852-725-65
- Lots / codes
Lot: 12/19/18 0242 72565S BUD: 3/31/19
- Quantity
- 160 syringes
- Company
- Advanced Pharma Inc., Houston, TX
- Distribution
- TX, WA
- Initiated
- January 15, 2019 · Voluntary: Firm initiated
- Classified
- February 8, 2019
- Reported
- January 30, 2019
- Ended
- May 1, 2019
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Heparin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.